Avalo Therapeutics (AVTX) Net Margin Growth (3y) (2019 - 2025)
Powered by 
Analysis
Avalo Therapeutics (AVTX) Net Margin Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -5,319.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 31,387.00 |
| 10 | Avalo Therapeutics | 835.85 Mn | 835.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -963,130.00 |
| Sep 30, 2024 | 1.05 Mn |
| Dec 31, 2023 | -38,552.00 |
| Sep 30, 2023 | -100,382.00 |
| Jun 30, 2023 | -28,502.00 |
| Mar 31, 2023 | -133,058.00 |
| Dec 31, 2022 | -137,419.00 |
| Sep 30, 2022 | 20,382.00 |
| Jun 30, 2022 | -80,938.00 |
| Mar 31, 2022 | -159,319.00 |
| Dec 31, 2021 | -878,678.00 |
| Sep 30, 2021 | -68,475.00 |
| Jun 30, 2021 | -38,426.00 |
| Mar 31, 2021 | -639,965.00 |
| Dec 31, 2020 | -88,318.00 |
| Sep 30, 2020 | -128,620.00 |
| Jun 30, 2020 | 15,058.00 |
| Mar 31, 2020 | -25,491.00 |
| Dec 31, 2019 | 117,949.00 |